USC-Norris Comprehensive Cancer Center Trials

USC-Norris Comprehensive Cancer Center	Welcome, Profile Billing Logout

USC-Norris Comprehensive Cancer Center

Welcome, Profile Billing Logout

1 Trial

1 Trials

Active Trials Industry lead sponsorIndustry collaborator

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Lenz, Heinz Josef

NCT05309187: Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors

Completed

IO-202, IO-202 + pembrolizumab combination therapy, IO-202 + Keytruda combination therapy, RP2D of IO-202 + pembrolizumab combination therapy in multiple solid tumor types, RP2D of IO-202 + Keytruda combination therapy

Immune-Onc Therapeutics

Solid Tumor, Adult

03/24

05/24

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites